PLSH (Panacea Life Sciences Holdings) Revenue: $0.86 Mil (TTM As of Sep. 2025)


What is Panacea Life Sciences Holdings Revenue?

Panacea Life Sciences Holdings PLSH Revenue is $0.86 Mil as of Sep. 2025. The stock has 6 warning signs investors should review.

Panacea Life Sciences Holdings's revenue for the three months ended in Sep. 2025 was $0.05 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2025 was $0.86 Mil. Panacea Life Sciences Holdings's Revenue per Share for the three months ended in Sep. 2025 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $0.04.

Warning Sign:

Panacea Life Sciences Holdings Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Panacea Life Sciences Holdings was -57.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -29.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 4 years, Panacea Life Sciences Holdings's highest 3-Year average Revenue per Share Growth Rate was -29.70% per year. The lowest was -29.70% per year. And the median was -29.70% per year.

Panacea Life Sciences Holdings  (OTCPK:PLSH) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Panacea Life Sciences Holdings Revenue Related Terms

Panacea Life Sciences Holdings Revenue Historical Data

* Premium members only.

The historical data trend for Panacea Life Sciences Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Life Sciences Holdings Revenue Chart

Panacea Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Revenue
9.02 2.06 1.63 2.39

Panacea Life Sciences Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.17 0.95 0.60 0.22 0.05

PLSH vs SKYI, IMCC, CBDY: Revenue Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panacea Life Sciences Holdings Revenue vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Panacea Life Sciences Holdings's Revenue falls into.


Panacea Life Sciences Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $0.86 Mil mean?
Panacea Life Sciences Holdings (PLSH) has a Revenue of $0.86 Mil as of Sep. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Panacea Life Sciences Holdings and its competitors.
Is Panacea Life Sciences Holdings' Revenue too high?
Panacea Life Sciences Holdings' current Revenue is $0.86 Mil.
How does Panacea Life Sciences Holdings' Revenue compare to SKYI and IMCC?
Panacea Life Sciences Holdings' Revenue of $0.86 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Drug Manufacturers company?
A good Revenue depends on the Drug Manufacturers industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Panacea Life Sciences Holdings and its competitors. Panacea Life Sciences Holdings's current Revenue is $0.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current Revenue of $0.86 Mil. The current Revenue is $0.86 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current Revenue is $0.86 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Panacea Life Sciences Holdings Business Description

Address 5910 South University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.